Heritage Trust CO Vertex Pharmaceuticals Inc Transaction History

Heritage Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $649,421 - $756,989	-3,137 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $39,331 - $52,457	-190 Reduced 5.71%	3,137 $742,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $45,761 - $54,254	179 Added 5.69%	3,327 $906,000
Q2 2020 Aug 04, 2020	BUY	$225.48 - $295.8 $709,811 - $931,178	3,148 New	3,148 $914,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $7,531 - $8,956	-46 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $6,813 - $7,463	46	46 $7,000

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

Stay updated on Heritage Trust CO with notifications on news.